Pharmaceuticals

Investment norms eased for PLI scheme for bulk drugs, medical devices

02 Nov 2020

Bharat Biotech gets nod for Phase-III trials of Covaxin

26 Oct 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

DRL gets DCGI nod for phase 2/3 human trials of Sputnik V Covid vaccine

19 Oct 2020

Bristol Myers Squibb to acquire MyoKardia for $13.1 billion in cash

07 Oct 2020

Govt targets 10,500 Janaushadhi Kendras by end-March 2025

19 Sep 2020

Ensure Covid-19 vaccine trials follow `scientific process’: MNCs

10 Sep 2020

Combined turnover of Janaushadhi Kendras nearly double to Rs146.59 cr in Q2 FY21

07 Sep 2020

Tata Motors, Hyundai win EESL order for 250 electric vehicles

04 Sep 2020

CCI nod for takeover of JB Chemicals, 4 other Indian firms by foreign funds

26 Aug 2020

Reliance acquires majority stake in onlin4e pharma Netmeds for Rs620 cr

19 Aug 2020

Kodak to turn drug maker with $765 m US govt loan

30 Jul 2020

Kodak, which is known more for its cameras and imaging business, will now produce active pharmaceutical ingredients (API) in the country, helping the United States reduce dependency on other countries

Govt launches schemes for local production of bulk drugs, medical devices

29 Jul 2020

Bangladesh's Beximco, five other drug firms to produce COVID-19 drug remdesivir

05 May 2020

Dr Reddy’s to acquire select businesses of Wockhardt for Rs1.850 cr

13 Feb 2020

Wockhardt would transfer 62 of its brands in therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines as also its plant in Baddi, Himachal Pradesh along with all employees, including related sales and marketing teams to Dr Reddy’s on a slump sale basis

Lupin to sell entire stake in Japanese subsidiary Kyowa for over Rs3,702 cr

12 Nov 2019

Sun Pharma swings to Q2 net profit of Rs1,062 cr

07 Nov 2019

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

Johnson & Johnson fined $8 bn for hiding fact about drug causing breast growth in men

10 Oct 2019

Drug regulator sounds health alert on antacid ranitidine

25 Sep 2019

Roche’s $4.3 billion takeover offer for Spark extended till 1 October

05 Sep 2019

In-vitro diagnostics firm Transasia-Erba doubles R&D spending

13 Aug 2019

Dr Reddy's Q1 net profit rises 45% to Rs662.8cr on one-off gains

30 Jul 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Pfizer to acquire cancer drug maker Array Biopharma for $10.6 bn

18 Jun 2019

Array’s Braftovi and Mektovi, launched last July for the deadliest form of skin cancer at a price of $22,000 per month, had sales of around $72 million over their first nine months, besides revenue from royalty and licensing deals